» Articles » PMID: 31394311

Proteomics Analysis of Asthenozoospermia and Identification of Glucose-6-phosphate Isomerase As an Important Enzyme for Sperm Motility

Overview
Journal J Proteomics
Publisher Elsevier
Specialty Biochemistry
Date 2019 Aug 9
PMID 31394311
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Asthenozoospermia, in which sperm motility is affected, is one of the primary causes of male infertility. However, the exact mechanism responsible for the defective motility remains unknown. It is important to identify the precise proteins or pathways involved in sperm motility. The present study analyzed five asthenozoospermic sperm samples and five healthy controls using TMT-based quantitative method and identified 152 differentially expressed proteins, with 84 upregulated and 68 downregulated in asthenozoospermia. Four proteins (GPI, MDH1, PGAM1 and PGAM2) were found in several over-represented energy metabolism pathways using bioinformatics analysis. Glucose-6-phosphate isomerase (GPI), a rate-limiting enzyme converting glucose-6-phosphate to fructose-6-phosphate, was found to be significantly decreased in asthenozoospermia by Western blotting and ELISA on an extended sample size. Furthermore, substitution of glucose with fructose-6-phosphate significantly promoted asthenozoospermic sperm motility in vitro. Taken together, our results suggest that the poor motility of sperm in asthenozoospermia may partly result from defects in GPI-associated energy metabolism. SIGNIFICANCE: To identify the key proteins or pathways involved in sperm motility, the accurate TMT-based quantitative method was applied to characterize protein profiles of asthenozoospermic sperm. GPI, an enzyme involved in energy metabolism, was found to be differentially abundant, and validated by extended sample analysis. The supplement of the product of GPI, fructose-6-phosphate, could significantly improve sperm motility. Our study could provide new insights into the molecular basis of sperm motility and the improvement of motility in asthenozoospermia.

Citing Articles

Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches.

Li Z, Li N, Ndzie Noah M, Shao Q, Zhan X EPMA J. 2024; 15(4):711-737.

PMID: 39635022 PMC: 11612093. DOI: 10.1007/s13167-024-00385-1.


A Comparison of White and Yellow Seminal Plasma Phosphoproteomes Obtained from Turkey () Semen.

Rafalska K, Orzolek A, Ner-Kluza J, Wysocki P Int J Mol Sci. 2024; 25(18).

PMID: 39337428 PMC: 11432639. DOI: 10.3390/ijms25189941.


Age-dependent variations in proteomic characteristics of spermatozoa in Simmental bull.

Satrio F, Karja N, Setiadi M, Kaiin E, Pardede B, Purwantara B Front Vet Sci. 2024; 11:1393706.

PMID: 39183752 PMC: 11343614. DOI: 10.3389/fvets.2024.1393706.


The role of HnrnpF/H as a driver of oligoteratozoospermia.

Netherton J, Ogle R, Robinson B, Molloy M, Krisp C, Velkov T iScience. 2024; 27(7):110198.

PMID: 39092172 PMC: 11292545. DOI: 10.1016/j.isci.2024.110198.


The antioxidant effects of butylated hydroxytoluene on cryopreserved goat sperm from a proteomic perspective.

Li C, Allai L, Liang J, Lv C, Zhao X, Ni X PeerJ. 2024; 12:e17580.

PMID: 38978759 PMC: 11229688. DOI: 10.7717/peerj.17580.